FDA NDC Directory · JSON-LD · Markdown

BORTEZOMIB

NDC 55150-337 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerEugia US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA212825
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsBORTEZOMIB (3.5 mg/1)
Marketing started20220502
Package count1

External sources

Source: openFDA. Public-domain (CC0).